Daxor (DXR) Competitors $9.86 +0.03 (+0.31%) As of 07/7/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DXR vs. ELMD, PROF, INGN, KRMD, CVRX, LNSR, AVR, PDEX, RCEL, and LAKEShould you be buying Daxor stock or one of its competitors? The main competitors of Daxor include Electromed (ELMD), Profound Medical (PROF), Inogen (INGN), KORU Medical Systems (KRMD), CVRx (CVRX), LENSAR (LNSR), Anteris Technologies Global (AVR), Pro-Dex (PDEX), Avita Medical (RCEL), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry. Daxor vs. Its Competitors Electromed Profound Medical Inogen KORU Medical Systems CVRx LENSAR Anteris Technologies Global Pro-Dex Avita Medical Lakeland Industries Electromed (NYSE:ELMD) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation. Do institutionals & insiders believe in ELMD or DXR? 40.8% of Electromed shares are owned by institutional investors. Comparatively, 1.3% of Daxor shares are owned by institutional investors. 14.0% of Electromed shares are owned by insiders. Comparatively, 59.5% of Daxor shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media prefer ELMD or DXR? In the previous week, Electromed had 1 more articles in the media than Daxor. MarketBeat recorded 1 mentions for Electromed and 0 mentions for Daxor. Electromed's average media sentiment score of 0.00 equaled Daxor'saverage media sentiment score. Company Overall Sentiment Electromed Neutral Daxor Neutral Which has stronger valuation & earnings, ELMD or DXR? Electromed has higher revenue and earnings than Daxor. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElectromed$61.44M2.75$5.15M$0.7925.47DaxorN/AN/AN/AN/AN/A Do analysts prefer ELMD or DXR? Electromed presently has a consensus price target of $38.00, indicating a potential upside of 88.87%. Daxor has a consensus price target of $25.00, indicating a potential upside of 153.55%. Given Daxor's higher probable upside, analysts plainly believe Daxor is more favorable than Electromed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Electromed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00Daxor 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ELMD or DXR more profitable? Electromed has a net margin of 11.34% compared to Daxor's net margin of 0.00%. Electromed's return on equity of 15.71% beat Daxor's return on equity.Company Net Margins Return on Equity Return on Assets Electromed11.34% 15.71% 13.37% Daxor N/A N/A N/A Which has more risk & volatility, ELMD or DXR? Electromed has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, Daxor has a beta of -0.07, meaning that its stock price is 107% less volatile than the S&P 500. SummaryElectromed beats Daxor on 9 of the 12 factors compared between the two stocks. Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DXR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DXR vs. The Competition Export to ExcelMetricDaxorMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$47.55M$3.91B$5.52B$9.02BDividend YieldN/A1.27%5.24%4.05%P/E RatioN/A36.5527.2220.08Price / SalesN/A100.13381.5993.26Price / CashN/A24.0326.2128.59Price / BookN/A4.367.945.55Net IncomeN/A$189.47M$3.17B$248.49M7 Day Performance2.18%-2.46%1.79%4.87%1 Month Performance6.59%-6.39%1.27%6.63%1 Year Performance12.30%7.44%33.57%20.38% Daxor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DXRDaxorN/A$9.86+0.3%$25.00+153.5%+16.0%$47.55MN/A0.0037ELMDElectromed1.5022 of 5 stars$21.65+1.9%$38.00+75.5%+41.6%$181.56M$61.44M28.87160PROFProfound Medical2.6607 of 5 stars$6.20+3.2%$11.50+85.5%-31.6%$180.62M$10.68M-5.08150INGNInogen4.3835 of 5 stars$7.05+5.7%$11.00+56.0%-12.0%$179.34M$335.70M-6.131,030KRMDKORU Medical Systems2.1985 of 5 stars$3.56+3.8%$4.50+26.4%+45.6%$158.26M$33.65M-32.3680News CoverageGap UpHigh Trading VolumeCVRXCVRx2.7436 of 5 stars$6.07+6.1%$14.50+138.9%-46.7%$149.13M$51.29M-2.78160LNSRLENSAR1.3568 of 5 stars$12.49+2.0%$15.00+20.1%+187.2%$144.34M$53.49M-2.58110AVRAnteris Technologies GlobalN/A$4.03+6.1%$16.50+309.4%N/A$137.04M$2.70M0.00138Positive NewsPDEXPro-Dex2.4553 of 5 stars$42.37+1.3%$56.00+32.2%+164.9%$136.38M$53.84M15.13140Positive NewsHigh Trading VolumeRCELAvita Medical0.8507 of 5 stars$4.94-3.9%$16.50+234.0%-35.9%$135.87M$64.25M-2.26130High Trading VolumeLAKELakeland Industries4.8193 of 5 stars$14.04+0.1%$26.00+85.2%-37.0%$133.49M$167.21M-4.662,100Positive NewsHigh Trading Volume Related Companies and Tools Related Companies Electromed Alternatives Profound Medical Alternatives Inogen Alternatives KORU Medical Systems Alternatives CVRx Alternatives LENSAR Alternatives Anteris Technologies Global Alternatives Pro-Dex Alternatives Avita Medical Alternatives Lakeland Industries Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DXR) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Daxor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DXR Stock Alerts